Search
 
Company

LEK PHARMACEUTICALS D.D. (Sandoz)

15 Case(s) (Last 5 Years)

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
10552562 Process for the preparation of amorphous calcium salt of atorvastatin C07D Apr 8, 2004 Feb 4, 2013
10545111 Therapeutic system comprising amoxicillin and clavulanic acid A61K Feb 19, 2004 May 15, 2013
10544920 Coated particles and pharmaceutical dosage forms A61K Feb 10, 2004 Apr 13, 2008
10524993 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods C07D, A61K Jan 28, 2004 Sep 17, 2007
10539501 Treatment of psychostimulant addiction A61P, A61K Dec 10, 2003 Dec 14, 2009
10577285 Stable pharmaceutical composition granulocyte-colony stimulating factor A61K, C07K Nov 3, 2003 Sep 7, 2009
10698009 Process for obtaining HMG-CoA reductase inhibitors of high purity A61K, C07D Oct 29, 2003 Nov 27, 2006
10683683 Stablized pharmaceutical composition comprising an amorphous active substance A61K Oct 9, 2003 Aug 3, 2008
10655263 Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor A61K Sep 3, 2003 Jul 15, 2008
10522827 Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in E. coli C07H, C12P, C12N, C07K Jul 27, 2003 Feb 1, 2010
10521298 Stable pharmaceutical composition comprising erythropoietin C12P, A61K Jul 13, 2003 May 18, 2009
10521294 Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them A61K, C07D Jul 8, 2003 Jul 13, 2009
10614534 Process for the preparation of amorphous atorvastatin A61K Jul 6, 2003 May 9, 2005
10518731 Rapidly disintegrating tablet A61K Jun 19, 2003 Nov 14, 2011
10522826 Process for the production of a heterologous protein Jun 10, 2003 Oct 5, 2012
10320285 Salts of HMG-CoA reductase inhibitors C07C, C07D Dec 15, 2002 Jan 3, 2005
10499315 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor C07K, A61K Dec 4, 2002 Aug 18, 2013
10497328 Thrombin inhibitors A61K, C07D Dec 2, 2002 Apr 27, 2009
10298187 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same A61K Nov 14, 2002 Oct 18, 2004
10521296 Stable pharmaceutical composition comprising erythropoietin C07K Nov 7, 2002 Feb 10, 2014
Menu